Prospective randomized trial of neoadjuvant chemotherapy during the 'wait period' following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
J MooreP Hewett

Abstract

The aim was to determine whether the addition of additional cycles of chemotherapy during the 'wait period' following neoadjuvant chemoradiotherapy for rectal cancer improves the pathological complete response (pCR) rate. Rectal cancer patients were randomly allocated either to a standard 10 week wait period before surgery (standard chemoradiotherapy, SCRT) or to receive three cycles of fluorouracil based chemotherapy following chemoradiotherapy during a similar 10 week wait (extended chemoradiotherapy, XCRT). The primary end-point was pCR as determined by blinded pathological assessment. Forty-nine patients were randomized (SCRTn = 24, XCRTn = 25). pCR occurred in 10 patients overall but there was no significant difference in pCR between the groups (SCRTn = 6, XCRTn = 4, P = 0.49). The addition of three cycles of 5-fluorouracil/leucovorin in a 10 week wait period after conventional chemoradiotherapy seems to result in similar pCR rates in patients with locally advanced rectal cancer based on this small randomized trial.

References

Nov 1, 1982·International Journal of Radiation Oncology, Biology, Physics·J E ByfieldF Kulhanian
Jan 1, 1997·International Journal of Colorectal Disease·O DworakA Hoffmann
Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·C A M MarijnenUNKNOWN Cooperative investigators of the Dutch Colerectal Cancer Group
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GerardPatrice Adeleine
Oct 22, 2004·The New England Journal of Medicine·Rolf SauerUNKNOWN German Rectal Cancer Study Group
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Alexander K P ChanDouglas Johnson
Oct 26, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claus RödelChristian Wittekind
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GérardLaurent Bedenne
Feb 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Angelita Habr-GamaIvan Cecconello
Feb 6, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·P SangheraA Hartley
Apr 15, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·P HeudelG Freyer
Nov 14, 2008·International Journal of Radiation Oncology, Biology, Physics·Federica BertoliniPier Franco Conte
Feb 24, 2009·International Journal of Radiation Oncology, Biology, Physics·Hee Chul ParkSunil Krishnan
May 14, 2009·Anti-cancer Drugs·Karoline HorisbergerUNKNOWN MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren)
Jul 8, 2009·International Journal of Colorectal Disease·Seong Dae LeeJae Hwan Oh
Jan 19, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Hendrik Andreas WolffHans Christiansen
Apr 16, 2011·Annals of Surgery·Julio Garcia-AguilarUNKNOWN Timing of Rectal Cancer Response to Chemoradiation Consortium
Jan 8, 2014·Journal of Cancer·Avery S WalkerScott R Steele

❮ Previous
Next ❯

Citations

Oct 15, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diana D Shi, Harvey J Mamon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.